Filing Flows › AstraZeneca (AZN) › Net income
AstraZeneca (AZN) net income by quarter
AstraZeneca's net income was $3.1B in Q3 2026 (third quarter 2026), +24% from Q2 2026. Over the last 5 quarters it ranged from $2.4B (Q2 2025) to $3.1B (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.1B | +24% | +23% |
| Q2 2026 | $2.5B | -19% | +2% |
| Q1 2026 | $3.1B | +22% | — |
| Q3 2025 | $2.5B | +4% | — |
| Q2 2025 | $2.4B | — | — |
Q3 2026 at a glance
AstraZeneca, Q3 2026: revenue $16.2B (+7% year over year), operating margin 27.1%, net earnings $3.1B, operating cash flow $5.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is AstraZeneca's net income?
AstraZeneca's net income was $3.1B in Q3 2026 (third quarter 2026), +24% from Q2 2026.
How has AstraZeneca's net income changed?
Over the last 5 quarters it ranged from $2.4B (Q2 2025) to $3.1B (Q3 2026).